University of Michigan Wins $53M in Renewed CTSA Funding | GenomeWeb

NEW YORK (GenomeWeb News) – The University of Michigan has reeled in $53 million in funding from the National Institutes of Health to continue operations at its Michigan Institute for Clinical & Health Research, or MICHR, which funds research grants, provides training and services to support translational science, and supports a biorepository.

The funding from the National Center for Advancing Translational Sciences will renew MICHR's Clinical and Translational Science Award for a second five-year term, UM said this week.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.